Sivik Global Healthcare’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-165,000
| Closed | -$3.35M | – | 87 |
|
|
2017
Q3 | $3.35M | Sell |
165,000
-85,000
| -34% | -$1.73M | 1.14% | 34 |
|
|
2017
Q2 | $4.03M | Buy |
250,000
+81,970
| +49% | +$1.32M | 1.47% | 31 |
|
|
2017
Q1 | $2.13M | Buy |
168,030
+63,030
| +60% | +$797K | 0.99% | 42 |
|
|
2016
Q4 | $1.39M | Sell |
105,000
-25,000
| -19% | -$331K | 0.66% | 47 |
|
|
2016
Q3 | $3.08M | Buy |
+130,000
| New | +$3.08M | 1.55% | 30 |
|
|
2016
Q1 | – | Sell |
-47,369
| Closed | -$2.03M | – | 69 |
|
|
2015
Q4 | $2.03M | Sell |
47,369
-2,631
| -5% | -$112K | 0.96% | 49 |
|
|
2015
Q3 | $1.76M | Sell |
50,000
-5,669
| -10% | -$200K | 0.85% | 48 |
|
|
2015
Q2 | $2.56M | Buy |
55,669
+15,669
| +39% | +$719K | 0.89% | 45 |
|
|
2015
Q1 | $1.88M | Sell |
40,000
-9,600
| -19% | -$450K | 0.64% | 63 |
|
|
2014
Q4 | $1.57M | Buy |
+49,600
| New | +$1.57M | 0.64% | 62 |
|
|
2014
Q3 | – | Sell |
-50,000
| Closed | -$1.5M | – | 75 |
|
|
2014
Q2 | $1.5M | Buy |
+50,000
| New | +$1.5M | 0.76% | 53 |
|